New peptide and protein drugs

Area of Science:

• Pharmacology and Biotechnology
• Drug Development
• Therapeutic Modalities

Background:

• Peptide and protein drugs represent a growing class of therapeutics.
• Biotechnology has enabled the production of diverse protein and peptide-based medicines.
• Innovation is also occurring in vaccine development using these agents.

Purpose of the Study:

• To review recent developments, current status, and future perspectives of peptide and protein drugs.
• To highlight the pharmacotherapeutic implications of these advanced medicines.
• To discuss the role of pharmacists in optimizing drug application and addressing ethical concerns.

Main Methods:

• Literature review and synthesis of current knowledge on peptide and protein therapeutics.
• Analysis of pharmacotherapeutic applications and biotechnological production methods.
• Discussion of clinical and ethical considerations for expanded use.

Main Results:

• Peptide and protein drugs encompass a wide range, including recombinant hormones, cytokines, growth factors, and monoclonal antibodies.
• New pharmacotherapeutic approaches are emerging due to increased usage and experience.
• Recombinant technology has overcome previous supply limitations for many physiological substances.

Conclusions:

• Optimal application schemes for peptide and protein drugs require further refinement, with a key role for clinical pharmacists.
• The success of recombinant technology raises ethical questions regarding unlimited application and indication expansion.
• Continued research and collaboration are essential for the safe and effective use of these vital medicines.